HealthEquity Financials

HealthEquity Inc

HQYNASDAQ

Trade with Public

$88.25

-0.35-0.4%

al cierre: Sep 25, 5:00 PM EST

$88.25

N/A

After hour: Sep 25, 4:00 PM EST

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Opciones Informe de acciones

HealthEquity Financials

HealthEquity (HQY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
HealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate

HealthEquity (NASDAQ:HQY) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.19 by 4.2 percent. This is a 14.81 percent increase over earnings of $1.08 per share from the same

Benzinga Newsdesk

PRO
HealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est

HealthEquity (NASDAQ:HQY) affirms FY2027 Adj EPS guidance from $4.66-$4.73 to $4.66-$4.73 vs $4.72 analyst estimate. Raises FY2027 sales outlook from $1.410 billion-$1.420 billion to $1.411 billion-$1.421 billion vs

Benzinga Newsdesk

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.88-$2.95 to $2.88-$2.96 vs $2.94 Est

HealthEquity (NASDAQ:HQY) raises FY2027 GAAP EPS guidance from $2.88-$2.95 to $2.88-$2.96 vs $2.94 analyst estimate..

Benzinga Newsdesk

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 Est

Benzinga Newsdesk

PRO
HealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B Est

Benzinga Newsdesk

PRO
HealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M Estimate

Benzinga Newsdesk

HealthEquity Inc

HealthEquity Financials

Earnings & Guidance News

PRO
HealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate

PRO
HealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.88-$2.95 to $2.88-$2.96 vs $2.94 Est

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 Est

PRO
HealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B Est

PRO
HealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M Estimate

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

HealthEquity Inc

HealthEquity Financials

Earnings & Guidance News

PROHealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate

PROHealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est

PROHealthEquity Raises FY2027 GAAP EPS Guidance from $2.88-$2.95 to $2.88-$2.96 vs $2.94 Est

PROHealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 Est

PROHealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B Est

PROHealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M Estimate

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

PRO
HealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate

PRO
HealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.88-$2.95 to $2.88-$2.96 vs $2.94 Est

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 Est

PRO
HealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B Est

PRO
HealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M Estimate